PD-L1 is expressed in 49–94% of biliary tract cancer cases, and its presence correlates with worse survival outcomes, including a 60% reduction in survival for patients with high PD-L1 expression at the tumor front (60, 61). This evidence concerns the gene CD274 and biliary tract cancer.